ArticleGMS health technology assessment2014
Why not integrate ethics in HTA: identification and assessment of the reasons.
Article in GMS health technology assessment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Methods for Practising Ethics in Research and Innovation: A Literature Review, Critical Analysis and Recommendations.Science and engineering ethics · 2018Pooled it
- Integrating ethical analysis in health technology assessment: opportunities and challenges.International journal of technology assessment in health care · 2026Article
- Ethics domains in full health technology assessment reports: an attempt to begin mapping the field.International journal of technology assessment in health care · 2025Article
- "Blanket rules just don't work": Qualitative exploration of the relative value of child and adult quality-adjusted life year (QALY) gains for health technology assessment.International journal of technology assessment in health care · 2025Article
- Ethics information retrieval in HTA: state of current practice.International journal of technology assessment in health care · 2023Article
- [Journal of preventive medicine and hygiene · 2021Article
- A survey of national ethics and bioethics committees.Bulletin of the World Health Organization · 2021Article
- Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment.BMC public health · 2020Article
- Evaluation of Ethical Analyses in Seven Reports from the European Network for Health Technology Assessment.International journal of technology assessment in health care · 2019Article
- HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".International journal of health policy and management · 2016Article
- Steps toward improving ethical evaluation in health technology assessment: a proposed framework.BMC medical ethics · 2016Article
- Ethical analysis in HTA of complex health interventions.BMC medical ethics · 2016Article
- Expanded HTA: Enhancing Fairness and Legitimacy.International journal of health policy and management · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
From the conception of HTA in the 1970s it has been argued that addressing ethical issues is an element of HTA, and many methods for integrating ethics in HTA have become available. However, despite almost 40 years with repeated intentions, only few HTA reports include ethical analysis. Why is this so? How come, ethics is a constituent part of HTA, there are many methods available, but ethics is rarely part of practical HTA work? This is the key question of this article and several reasons why ethics is not a part of HTA are identified. A) Ethicists are professional strangers in HTA. B) A common agreed methodology for integrating ethics is lacking. Ethics methodology appears to be C) deficient, D) insufficient, or E) unsuitable. F) Integrating ethics in HTA is neither efficient nor needed for successful HTA. G) Most moral issues are general, and are not specific to a given technology. H) All relevant ethical issues can be handled within other frameworks, e.g., within economics. I) Ethics can undermine or burst the foundation of HTA. Hence, there are many reasons why ethics is not an integrated part of HTA so many years after identifying ethics as constitutive to HTA. These reasons may all explain why it is so, but on closer scrutiny, they do not work as compelling arguments for not addressing ethical issues in HTA. Hence, the identified reasons may work well as explanations, but not as justifications. In order to move on from a situation of failure we can: Exclude ethics from definitions of HTA, and as a consequence, establish a separate kind of evaluation (Health Technology Evaluation - HTE). Take the existing definition seriously and actually integrate ethics in the performance of HTA practice. Amend, expand or change HTA so that ethics is more genuinely incorporated. Which of these options to choose is open for discussion, but we need to move away from a situation where we have a definition of HTA which does not correspond with HTA practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.